Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 87 companies set new 52-week lows.
Instil Bio Presents Subset Analysis Of Patients With Checkpoint-Refractory Advanced Melanoma From Compassionate Use Study At 2021 ESMO Congress
Instil Bio, Inc. ("Instil") (NASDAQ:TIL), a clinical-stage biopharmaceutical company focused on developing tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer, announced
53 Biggest Movers From Yesterday
Gainers
DICE Therapeutics, Inc. (NASDAQ: DICE) shares surged 117% to settle at $36.89 on Wednesday as the company priced its IPO at $17 per share.
Baird Initiates Coverage On Instil Bio with Outperform Rating, Announces Price Target of $34
Baird analyst Jack Allen initiates coverage on Instil Bio (NASDAQ:TIL) with a Outperform rating and announces Price Target of $34.
Instil Bio Q2 EPS $(0.27) Up From $(0.55) YoY
Instil Bio (NASDAQ:TIL) reported quarterly losses of $(0.27) per share. This is a 50.91 percent increase over losses of $(0.55) per share from the same period last year.